Yahoo Web Search

Search results

  1. Aug 16, 2024 · This release contains forward-looking information about Pfizer’s investigational modified RNA (modRNA) influenza vaccine candidates, potential next-generation mRNA flu and combination vaccine formulations, Pfizer’s and BioNTech’s mRNA-based combination vaccine candidate for influenza and COVID-19, the flu and COVID/flu combination ...

  2. Dec 12, 2020 · The emergency use authorization means that doses of the vaccine—made by Pfizer/BioNTech—can be shipped at any time; certain Americans could be vaccinated as soon as next week.

  3. In October 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) started 'rolling reviews' of the vaccines known as COVID‑19 Vaccine AstraZeneca (ChAdOx1-SARS-CoV-2) and Pfizer-BioNTech COVID‑19 Vaccine .

  4. Feb 11, 2021 · Operation Warp Speed was a federal effort that supported multiple COVID-19 vaccine candidates to speed up development. We analyzed the program's vaccine candidates and found that their development followed traditional practices, with some adaptations.

  5. Apr 19, 2024 · The FDA approved updated (2023–2024 formula) COVID-19 vaccines, which are expected to keep more people from getting seriously ill with the virus, including recent strains.

    • 065208055
    • kathy.katella-cofrancesco@yale.edu
  6. Because there is an urgent need for COVID-19 vaccines and the FDA’s vaccine approval process can take months to years, the FDA first gave emergency use authorization to COVID-19 vaccines based on less data than is normally required.

  7. Dec 10, 2020 · In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 days apart,...